Arrow General Trading FZE Pharmaceutical Import Profile — United Arab Emirates (DGFT 2022–2026)

Name: Arrow General Trading FZE Pharmaceutical Import Records from India — 3 Products, $11.5K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Arrow General Trading FZE — Pharmaceutical Importer Profile (2026) | 3 Products, $11.5K Trade | TransData Nexus

Arrow General Trading FZE

Pharmaceutical Importer · United Arab Emirates · Advanced Oncology Focus · $11.5K Total Trade · DGFT Verified

Arrow General Trading FZE is a pharmaceutical importer based in United Arab Emirates with a total trade value of $11.5K across 3 products in 1 therapeutic categories. Based on 10 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Arrow General Trading FZE sources from 3 verified Indian suppliers, with Rizlife Healthcare accounting for 75.4% of imports.

Arrow General Trading FZE — Import Portfolio & Supplier Network

Arrow General Trading FZE import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Arrow General Trading FZE?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Rizlife Healthcare	$224.5K	270	75.4%
Pregen Exports (india)	$73.0K	3	24.5%
Humble Healthcaare Limited	$74	3	0.0%

What Formulations Does Arrow General Trading FZE Import?

Formulation	Value	Ships
Lido injection (lidocaine hydrochlorideinjection USP 20MG/ML) mfd by:nixi laboratories pvt.ltd.kala-amb	$35.1K	1
Esomes injection (esomeprazole for injection 40 MG)mfd by:nixi laboratories pvt.ltd.kala-amb	$22.5K	1
Fopam injection (nefopam hydrochloride for injection 10MG/ML) mfd by:ang lifesciences india ltd baddi.solan	$15.4K	1
Idarubitec 10 MG (idarubicin hcl. for INJ. USP) bat. idlh4b3,idlh4b2 mfg aug-24,apr-24 exp july-26	$8.2K	2
Pharmaceutical products.aprezo-30 MG(apremilast tablets i.p 30 MG)batch no. 05240527, mfg dtd:april- 24 & exp	$8.2K	2
Pharmaceutical products.corovir 100 MG(remdesivir for injection)batch no, l25011a, mfg dtd: jan-25 & exp dtd: dec-	$7.1K	2
Folisurge 75 IU(recombinant human follicle stimulating hormone solution for INJ.75 IU/0.12ML)bat.7380035 m-7/24	$6.2K	2
Pharmaceutical products.kerendia 20 MG(finerenone film coated tablets 20 MG)bat.no.bxk5v41,mfg dt.july-24 & exp	$5.7K	2
Pharmaceutical products pirfenex- 200 MG(pirfenidone tablets IP 200MG)bat.no.4sn0897,mfg dtd: may- 24 & exp	$5.4K	2
Pharmaceutical products.olabir 150 MG(olaparib tablets 150 MG)batch no. act24180lb, mfg dtd: dec- 24 & exp dtd:nov-	$5.1K	2
Pharmaceutical products.budez cr(budesonide controlled release capsules)batch no.sif2661b,mfg dt.dec-24 & exp	$5.0K	2
Pharmaceutical products.cladrim 10 MG INJ(cladribine injection)batch no. 87240353aa, mfg dtd:sept- 24 & exp dtd	$4.7K	2
Tofajak 5 MG(tofacitinib tablets IP 5 MG)batch no. 4f30030,4f30050 mfg dt.aug- 24,oct-24 & exp dt.july- 26	$4.5K	2
Pharmaceutical products.indenza 160 MG(enzalutamide capsules 160 MG)batch no.bt24410a,mfg dtd:oct-24 & exp	$4.4K	2
Nelabin 250 MG INJ(nelarabine injection250 MG /50 ML (5MG/ML)bat.no.cse12010a mfg dt.dec- 24 exp dt.	$4.3K	2

Arrow General Trading FZE imports 141 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Cladribine	Advanced Oncology	$4.7K	2	2.0%	5
2	Cabozantinib	Advanced Oncology	$4.4K	6	3.4%	4
3	Axitinib	Advanced Oncology	$2.5K	2	2.6%	7

Arrow General Trading FZE imports 3 pharmaceutical products across 1 categories into United Arab Emirates totaling $11.5K.

Arrow General Trading FZE — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Arrow General Trading FZE is a pharmaceutical importer based in the United Arab Emirates (UAE), specializing in the procurement of finished pharmaceutical formulations. The company operates as a buyer, sourcing a range of pharmaceutical products from international suppliers, particularly from India. While specific details about its parent company are not publicly available, Arrow General Trading FZE plays a significant role in the UAE's pharmaceutical distribution network by facilitating the importation of essential medications.

The company's operations are primarily focused on importing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. This specialization indicates a strategic approach to meeting the demand for ready-to-use pharmaceutical products within the UAE market. By sourcing these products from established manufacturers, Arrow General Trading FZE contributes to the availability and accessibility of various medications in the region.

2Distribution Network

Arrow General Trading FZE's distribution network is centered in the UAE, with its operations based in Jebel Ali, Dubai. The company imports pharmaceutical products from India, utilizing the Jebel Ali Free Zone as a key logistics hub. This strategic location provides access to advanced logistics infrastructure, facilitating efficient customs clearance and distribution processes. While specific details about additional warehouse locations or logistics capabilities are not publicly disclosed, the company's choice of Jebel Ali underscores its commitment to leveraging the UAE's robust trade and logistics infrastructure.

3Industry Role

In the UAE's pharmaceutical supply chain, Arrow General Trading FZE functions as a pharmaceutical importer, focusing on the procurement of finished pharmaceutical formulations. By sourcing these products from international suppliers, particularly from India, the company ensures the availability of essential medications within the UAE market. This role is crucial in maintaining a steady supply of pharmaceutical products, thereby supporting the healthcare sector's needs in the region.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Arrow General Trading FZE

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Arrow General Trading FZE's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from India. In 2022, the company imported a total of $12,000 worth of pharmaceutical products from India, encompassing 10 shipments and 3 distinct products across a single therapeutic category. The top three products imported were Cladribine ($5,000), Cabozantinib ($4,000), and Axitinib ($2,000), collectively accounting for 100% of the company's pharmaceutical imports from India.

This concentrated sourcing approach suggests a strategic focus on specific high-value products, potentially to meet targeted therapeutic needs within the UAE market. However, such dependency on a limited number of products and suppliers may pose risks related to supply chain disruptions or changes in supplier dynamics. The stability of the relationship with Indian suppliers, particularly RIZLIFE HEALTHCARE, which accounted for 75.4% of the total import value, is critical to maintaining a consistent supply of these key pharmaceutical products.

2Supply Chain Resilience

Arrow General Trading FZE's supply chain resilience is closely tied to its reliance on Indian suppliers, especially RIZLIFE HEALTHCARE, which has been a primary source of its pharmaceutical imports. The company's import data indicates a concentration of shipments from this supplier, highlighting the importance of a stable and reliable relationship. While the focus on a single supplier may streamline procurement processes, it also exposes the company to potential risks associated with supply chain disruptions, such as production delays or logistical challenges.

Importing Pharmaceuticals into United Arab Emirates — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United Arab Emirates

1Regulatory Authority & Framework

In the UAE, the regulation of medical products, including pharmaceuticals, is governed by the Ministry of Health and Prevention (MOHAP). The Federal Decree-Law No. (8) of 2019 on Medical Products, Pharmacy Profession, and Pharmaceutical Establishments outlines the legal framework for the import, distribution, and marketing of medical products in the country. This legislation establishes the requirements for obtaining marketing approvals, import permits, and the responsibilities of pharmaceutical establishments. (uaelegislation.gov.ae)

The MOHAP is responsible for ensuring the safety, efficacy, and quality of medical products circulating within the UAE. This includes overseeing the registration of pharmaceutical products, monitoring their distribution, and enforcing compliance with established standards. Pharmaceutical establishments, such as Arrow General Trading FZE, must adhere to these regulations to operate legally within the UAE market.

2Import Licensing & GMP

To import pharmaceutical products into the UAE, companies like Arrow General Trading FZE must obtain an import license from the MOHAP. This license is contingent upon the fulfillment of specific conditions, including the submission of relevant documentation and compliance with regulatory standards. Additionally, the MOHAP requires that imported pharmaceutical products be manufactured in facilities that hold valid Good Manufacturing Practice (GMP) certifications recognized by the UAE. These certifications ensure that the manufacturing processes meet the quality standards necessary for the production of safe and effective medical products. (uaelegislation.gov.ae)

Arrow General Trading FZE — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Arrow General Trading FZE's focus on importing pharmaceutical products within the Advanced Oncology therapeutic category indicates a strategic alignment with the UAE's healthcare priorities. The selection of Cladribine, Cabozantinib, and Axitinib suggests a targeted approach to addressing specific oncological treatment needs. This product strategy is likely driven by market demand for advanced oncology therapies and the company's objective to provide high-quality, specialized medications to healthcare providers and patients in the UAE.

2Sourcing Profile

Arrow General Trading FZE's sourcing strategy is centered on importing generic pharmaceutical formulations from India, focusing on specific products within the Advanced Oncology category. This approach allows the company to leverage India's established pharmaceutical manufacturing capabilities and cost-effective production processes. By concentrating on a select range of products, the company aims to meet the specialized needs of the UAE market while maintaining a streamlined procurement process.

3Market Positioning

Based on its product mix, Arrow General Trading FZE primarily serves the hospital and specialized healthcare sectors within the UAE. The importation of advanced oncology medications positions the company as a key supplier of specialized treatments, catering to the needs of healthcare providers involved in cancer care. This market positioning underscores the company's commitment to enhancing the quality and availability of specialized pharmaceutical products in the UAE.

Seller's Guide — How to Become a Supplier to Arrow General Trading FZE

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Arrow General Trading FZE, particularly in the Advanced Oncology therapeutic category. The company's focused product strategy and reliance on a limited number of suppliers suggest potential gaps in its current sourcing that could be addressed by introducing additional products or alternative suppliers. Indian exporters with a strong track record in oncology pharmaceuticals and the ability to meet the UAE's regulatory standards may find a receptive partner in Arrow General Trading FZE.

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Arrow General Trading FZE

What products does Arrow General Trading FZE import from India?

Arrow General Trading FZE imports 3 pharmaceutical products across 1 categories. Top imports: Cladribine ($4.7K), Cabozantinib ($4.4K), Axitinib ($2.5K).

Who supplies pharmaceuticals to Arrow General Trading FZE from India?

Arrow General Trading FZE sources from 3 verified Indian suppliers. The primary supplier is Rizlife Healthcare (75.4% of imports, $224.5K).

What is Arrow General Trading FZE's total pharmaceutical import value?

Arrow General Trading FZE's total pharmaceutical import value from India is $11.5K, based on 10 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Arrow General Trading FZE focus on?

Arrow General Trading FZE imports across 1 categories. The largest: Advanced Oncology (100.0%).

Get Full Arrow General Trading FZE Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.